Press Release

Allergy Diagnostics Market Size to Witness CAGR of 9.9% from 2019-2025
October 2020

Allergy Diagnostics Market Size to Witness CAGR of 9.9% from 2019-2025

According to iCognition Insights, the global allergy diagnostics market size was estimated to be USD 4,419.1 million in 2019. Major factors responsible for the growth of this market are rising prevalence of allergic diseases such as asthma, urticaria, rhinitis, eczema, angioedema, and conjunctivitis; increasing pollution; change in dietary habits; and growing healthcare expenditure.

Based on product, the market is segmented into assay kits, instruments, and services. By test type, the market is divided into in-vivo and in-vitro tests. Based on allergen type, the market is segmented into drugs, food, and inhaled. By end-user, the market is divided into hospitals, diagnostic laboratories, and others.

In 2019, North America was the highest revenue-generating region in the global market and is anticipated to hold its dominance over the forecast period. This is majorly due to increasing healthcare expenditure, rising allergic diseases & its awareness, and rapid adoption of advanced diagnostic in-vitro tests. Europe holds the second largest position in terms of market size across the globe due to the existence of major pharmaceutical players in this region.

Some of the key players in the allergy diagnostics market are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), bioMérieux SA (France), HOB Biotech Group Suzhou Co., Ltd. (China), Lincoln Diagnostics Inc. (U.S.), HYCOR Biomedical (U.S.), Danaher Corporation (U.S.), Omega Diagnostics Group PLC (UK), Stallergenes Greer (UK), and Alcon (Switzerland).

Allergy Diagnostics Market: Key Datapoints-

  • Rising prevalence of allergic diseases, increasing pollution, and change in dietary habits are boosting the market growth
  • In 2019, the assay kits segment accounted for the largest share and is expected to hold its dominance over the forecast period due to increasing focus of market players towards product advancement
  • The in-vitro segment is expected to show lucrative growth over the forecast period. This is attributed to increased demand for minimally invasive diagnostic methods and rising clinical laboratory automation
  • In 2019, the inhaled allergen segment dominated the market due to rising respiratory allergic diseases such as asthma, development of new allergens, and increasing demand for allergy testing
  • Diagnostics laboratories segment accounted for the largest market share in 2019 owing to the intensive usage of immunoassay tests in testing of allergies in patient
  • Asia Pacific is projected to exhibit attractive growth over the forecast period owing to the rising demand for less invasive diagnostic tests, unmet clinical needs, and development in healthcare infrastructure

Allergy Diagnostics Market Scope-

Allergy Diagnostics Market, By Product (Revenue, 2017-2025, USD Million)

  • Instruments
    • Luminometers
    • Immunoassay Analyzers
    • ELISA Analyzers
    • Others
  • Assay Kits
  • Services

Allergy Diagnostics Market, By Test Type (Revenue, 2017-2025, USD Million)

  • In-vivo
  • In-vitro

Allergy Diagnostics Market, By Allergen Type (Revenue, 2017-2025, USD Million)

  • Food Allergens
  • Inhaled Allergens
  • Drug Allergens
  • Other Allergens

Allergy Diagnostics Market, By End-User (Revenue, 2017-2025, USD Million)

  • Hospitals
  • Diagnostic Laboratories
  • Others

Allergy Diagnostics Market, By Region (Revenue, 2017-2025, USD Million)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Request a free sample copy or view report summary:

Allergy Diagnostics Market Analysis by Product